カテゴリ： 世界, 医療/バイオ, QYResearch

臨床試験用CROの世界市場2023年：フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル

■ 英語タイトル：Global CRO in Clinical Trials Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7758）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7758
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[臨床試験用CROの世界市場2023年：フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は臨床試験用CROのグローバル市場について調査・分析し、世界の臨床試験用CRO市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル）、用途別セグメント分析（製薬、バイオ製薬、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Labcorp、IQVIA、Parexel、Syneos Health、PRA Health Sciences、PPD、ICON、MedPace、Wuxi AppTecなどが含まれています。臨床試験用CROのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、臨床試験用CRO市場規模を算出する際に考慮しました。

・臨床試験用CRO市場の概要
- 臨床試験用CROの種類別セグメント
- 世界の臨床試験用CRO市場規模：タイプ別分析（フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル）
- 臨床試験用CROの用途別セグメント
- 世界の臨床試験用CRO市場規模：用途別分析（製薬、バイオ製薬、その他）
- 世界の臨床試験用CRO市場規模予測（2018年-2029年）

・臨床試験用CRO市場の成長トレンド
- 臨床試験用CROの地域別市場規模（2018年-2029年）
- 臨床試験用CRO市場ダイナミクス
- 臨床試験用CROの業界動向
- 臨床試験用CRO市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル
- 世界の臨床試験用CROのタイプ別市場規模（2018年-2023年）
- 世界の臨床試験用CROのタイプ別市場規模（2024年-2029年）

・用途別セグメント：製薬、バイオ製薬、その他
- 世界の臨床試験用CROの用途別市場規模（2018年-2023年）
- 世界の臨床試験用CROの用途別市場規模（2024年-2029年）

・臨床試験用CROの地域別市場規模
- 北米の臨床試験用CRO市場規模（2018年-2029年）
- 米国の臨床試験用CRO市場規模（2018年-2029年）
- ヨーロッパの臨床試験用CRO市場規模（2018年-2029年）
- アジア太平洋の臨床試験用CRO市場規模（2018年-2029年）
- 中国の臨床試験用CRO市場規模（2018年-2029年）
- 日本の臨床試験用CRO市場規模（2018年-2029年）
- 韓国の臨床試験用CRO市場規模（2018年-2029年）
- インドの臨床試験用CRO市場規模（2018年-2029年）
- オーストラリアの臨床試験用CRO市場規模（2018年-2029年）
- 中南米の臨床試験用CRO市場規模（2018年-2029年）
- 中東・アフリカの臨床試験用CRO市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Labcorp、IQVIA、Parexel、Syneos Health、PRA Health Sciences、PPD、ICON、MedPace、Wuxi AppTec

・アナリストの観点/結論

・調査手法と情報源

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.
Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.
In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
Highlights
The global CRO in Clinical Trials market was valued at US$ 47210 million in 2022 and is anticipated to reach US$ 81290 million by 2029, witnessing a CAGR of 9.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%.
In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CRO in Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRO in Clinical Trials.
The CRO in Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global CRO in Clinical Trials market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRO in Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
Segment by Application
Pharmaceutical
Bio-pharm
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRO in Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRO in Clinical Trials Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Phase I Trial
1.2.3 Phase II Trial
1.2.4 Phase III Trial
1.2.5 Phase IV Trial
1.3 Market by Application
1.3.1 Global CRO in Clinical Trials Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Bio-pharm
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRO in Clinical Trials Market Perspective (2018-2029)
2.2 CRO in Clinical Trials Growth Trends by Region
2.2.1 Global CRO in Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CRO in Clinical Trials Historic Market Size by Region (2018-2023)
2.2.3 CRO in Clinical Trials Forecasted Market Size by Region (2024-2029)
2.3 CRO in Clinical Trials Market Dynamics
2.3.1 CRO in Clinical Trials Industry Trends
2.3.2 CRO in Clinical Trials Market Drivers
2.3.3 CRO in Clinical Trials Market Challenges
2.3.4 CRO in Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRO in Clinical Trials Players by Revenue
3.1.1 Global Top CRO in Clinical Trials Players by Revenue (2018-2023)
3.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2018-2023)
3.2 Global CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRO in Clinical Trials Revenue
3.4 Global CRO in Clinical Trials Market Concentration Ratio
3.4.1 Global CRO in Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRO in Clinical Trials Revenue in 2022
3.5 CRO in Clinical Trials Key Players Head office and Area Served
3.6 Key Players CRO in Clinical Trials Product Solution and Service
3.7 Date of Enter into CRO in Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRO in Clinical Trials Breakdown Data by Type
4.1 Global CRO in Clinical Trials Historic Market Size by Type (2018-2023)
4.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2024-2029)
5 CRO in Clinical Trials Breakdown Data by Application
5.1 Global CRO in Clinical Trials Historic Market Size by Application (2018-2023)
5.2 Global CRO in Clinical Trials Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CRO in Clinical Trials Market Size (2018-2029)
6.2 North America CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CRO in Clinical Trials Market Size by Country (2018-2023)
6.4 North America CRO in Clinical Trials Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRO in Clinical Trials Market Size (2018-2029)
7.2 Europe CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CRO in Clinical Trials Market Size by Country (2018-2023)
7.4 Europe CRO in Clinical Trials Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRO in Clinical Trials Market Size (2018-2029)
8.2 Asia-Pacific CRO in Clinical Trials Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CRO in Clinical Trials Market Size by Region (2018-2023)
8.4 Asia-Pacific CRO in Clinical Trials Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRO in Clinical Trials Market Size (2018-2029)
9.2 Latin America CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CRO in Clinical Trials Market Size by Country (2018-2023)
9.4 Latin America CRO in Clinical Trials Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRO in Clinical Trials Market Size (2018-2029)
10.2 Middle East & Africa CRO in Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CRO in Clinical Trials Market Size by Country (2018-2023)
10.4 Middle East & Africa CRO in Clinical Trials Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Detail
11.1.2 Labcorp Business Overview
11.1.3 Labcorp CRO in Clinical Trials Introduction
11.1.4 Labcorp Revenue in CRO in Clinical Trials Business (2018-2023)
11.1.5 Labcorp Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA CRO in Clinical Trials Introduction
11.2.4 IQVIA Revenue in CRO in Clinical Trials Business (2018-2023)
11.2.5 IQVIA Recent Development
11.3 Parexel
11.3.1 Parexel Company Detail
11.3.2 Parexel Business Overview
11.3.3 Parexel CRO in Clinical Trials Introduction
11.3.4 Parexel Revenue in CRO in Clinical Trials Business (2018-2023)
11.3.5 Parexel Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Detail
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health CRO in Clinical Trials Introduction
11.4.4 Syneos Health Revenue in CRO in Clinical Trials Business (2018-2023)
11.4.5 Syneos Health Recent Development
11.5 PRA Health Sciences
11.5.1 PRA Health Sciences Company Detail
11.5.2 PRA Health Sciences Business Overview
11.5.3 PRA Health Sciences CRO in Clinical Trials Introduction
11.5.4 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2018-2023)
11.5.5 PRA Health Sciences Recent Development
11.6 PPD
11.6.1 PPD Company Detail
11.6.2 PPD Business Overview
11.6.3 PPD CRO in Clinical Trials Introduction
11.6.4 PPD Revenue in CRO in Clinical Trials Business (2018-2023)
11.6.5 PPD Recent Development
11.7 ICON
11.7.1 ICON Company Detail
11.7.2 ICON Business Overview
11.7.3 ICON CRO in Clinical Trials Introduction
11.7.4 ICON Revenue in CRO in Clinical Trials Business (2018-2023)
11.7.5 ICON Recent Development
11.8 MedPace
11.8.1 MedPace Company Detail
11.8.2 MedPace Business Overview
11.8.3 MedPace CRO in Clinical Trials Introduction
11.8.4 MedPace Revenue in CRO in Clinical Trials Business (2018-2023)
11.8.5 MedPace Recent Development
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Detail
11.9.2 Wuxi AppTec Business Overview
11.9.3 Wuxi AppTec CRO in Clinical Trials Introduction
11.9.4 Wuxi AppTec Revenue in CRO in Clinical Trials Business (2018-2023)
11.9.5 Wuxi AppTec Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CRO in Clinical Trials Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Phase I Trial
Table 3. Key Players of Phase II Trial
Table 4. Key Players of Phase III Trial
Table 5. Key Players of Phase IV Trial
Table 6. Global CRO in Clinical Trials Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global CRO in Clinical Trials Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global CRO in Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global CRO in Clinical Trials Market Share by Region (2018-2023)
Table 10. Global CRO in Clinical Trials Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global CRO in Clinical Trials Market Share by Region (2024-2029)
Table 12. CRO in Clinical Trials Market Trends
Table 13. CRO in Clinical Trials Market Drivers
Table 14. CRO in Clinical Trials Market Challenges
Table 15. CRO in Clinical Trials Market Restraints
Table 16. Global CRO in Clinical Trials Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global CRO in Clinical Trials Market Share by Players (2018-2023)
Table 18. Global Top CRO in Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRO in Clinical Trials as of 2022)
Table 19. Ranking of Global Top CRO in Clinical Trials Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by CRO in Clinical Trials Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players CRO in Clinical Trials Product Solution and Service
Table 23. Date of Enter into CRO in Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CRO in Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global CRO in Clinical Trials Revenue Market Share by Type (2018-2023)
Table 27. Global CRO in Clinical Trials Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global CRO in Clinical Trials Revenue Market Share by Type (2024-2029)
Table 29. Global CRO in Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global CRO in Clinical Trials Revenue Market Share by Application (2018-2023)
Table 31. Global CRO in Clinical Trials Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global CRO in Clinical Trials Revenue Market Share by Application (2024-2029)
Table 33. North America CRO in Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe CRO in Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific CRO in Clinical Trials Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific CRO in Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific CRO in Clinical Trials Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America CRO in Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa CRO in Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa CRO in Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa CRO in Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 48. Labcorp Company Detail
Table 49. Labcorp Business Overview
Table 50. Labcorp CRO in Clinical Trials Product
Table 51. Labcorp Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 52. Labcorp Recent Development
Table 53. IQVIA Company Detail
Table 54. IQVIA Business Overview
Table 55. IQVIA CRO in Clinical Trials Product
Table 56. IQVIA Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 57. IQVIA Recent Development
Table 58. Parexel Company Detail
Table 59. Parexel Business Overview
Table 60. Parexel CRO in Clinical Trials Product
Table 61. Parexel Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 62. Parexel Recent Development
Table 63. Syneos Health Company Detail
Table 64. Syneos Health Business Overview
Table 65. Syneos Health CRO in Clinical Trials Product
Table 66. Syneos Health Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 67. Syneos Health Recent Development
Table 68. PRA Health Sciences Company Detail
Table 69. PRA Health Sciences Business Overview
Table 70. PRA Health Sciences CRO in Clinical Trials Product
Table 71. PRA Health Sciences Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 72. PRA Health Sciences Recent Development
Table 73. PPD Company Detail
Table 74. PPD Business Overview
Table 75. PPD CRO in Clinical Trials Product
Table 76. PPD Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 77. PPD Recent Development
Table 78. ICON Company Detail
Table 79. ICON Business Overview
Table 80. ICON CRO in Clinical Trials Product
Table 81. ICON Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 82. ICON Recent Development
Table 83. MedPace Company Detail
Table 84. MedPace Business Overview
Table 85. MedPace CRO in Clinical Trials Product
Table 86. MedPace Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 87. MedPace Recent Development
Table 88. Wuxi AppTec Company Detail
Table 89. Wuxi AppTec Business Overview
Table 90. Wuxi AppTec CRO in Clinical Trials Product
Table 91. Wuxi AppTec Revenue in CRO in Clinical Trials Business (2018-2023) & (US$ Million)
Table 92. Wuxi AppTec Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRO in Clinical Trials Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global CRO in Clinical Trials Market Share by Type: 2022 VS 2029
Figure 3. Phase I Trial Features
Figure 4. Phase II Trial Features
Figure 5. Phase III Trial Features
Figure 6. Phase IV Trial Features
Figure 7. Global CRO in Clinical Trials Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global CRO in Clinical Trials Market Share by Application: 2022 VS 2029
Figure 9. Pharmaceutical Case Studies
Figure 10. Bio-pharm Case Studies
Figure 11. Others Case Studies
Figure 12. CRO in Clinical Trials Report Years Considered
Figure 13. Global CRO in Clinical Trials Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global CRO in Clinical Trials Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global CRO in Clinical Trials Market Share by Region: 2022 VS 2029
Figure 16. Global CRO in Clinical Trials Market Share by Players in 2022
Figure 17. Global Top CRO in Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRO in Clinical Trials as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by CRO in Clinical Trials Revenue in 2022
Figure 19. North America CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America CRO in Clinical Trials Market Share by Country (2018-2029)
Figure 21. United States CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe CRO in Clinical Trials Market Share by Country (2018-2029)
Figure 25. Germany CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific CRO in Clinical Trials Market Share by Region (2018-2029)
Figure 33. China CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America CRO in Clinical Trials Market Share by Country (2018-2029)
Figure 41. Mexico CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa CRO in Clinical Trials Market Share by Country (2018-2029)
Figure 45. Turkey CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia CRO in Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Labcorp Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 48. IQVIA Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 49. Parexel Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 50. Syneos Health Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 51. PRA Health Sciences Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 52. PPD Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 53. ICON Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 54. MedPace Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 55. Wuxi AppTec Revenue Growth Rate in CRO in Clinical Trials Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 臨床試験におけるCROのグローバル市場展望 2023年-2029年：第Ⅰ相試験、第Ⅱ相試験、第Ⅲ相試験、第Ⅳ相試験
  • フルサービス臨床研究機関（CRO）の世界市場2023年：臨床CRO、前臨床CRO
  • 麻酔臨床情報システムの世界市場2023年：手術管理、人事管理、ユニバーサルクエリ、コンサルテーションティーチング
  • 臨床試験募集＆管理サービスの世界市場インサイト・予測（～2028年）
  • 臨床試験イメージングシステムの世界市場2023年：プロジェクト＆データ管理、臨床試験デザイン＆コンサルテーション、読解＆分析、オペレーショナルイメージング、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7758 )"臨床試験用CROの世界市場2023年：フェーズIトライアル、フェーズIIトライアル、フェーズIIIトライアル、フェーズIVトライアル" (英文：Global CRO in Clinical Trials Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。